These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720 [TBL] [Abstract][Full Text] [Related]
4. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794 [TBL] [Abstract][Full Text] [Related]
5. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice. Hill NJ; Van Gunst K; Sarvetnick N J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119 [TBL] [Abstract][Full Text] [Related]
7. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. Hussain S; Delovitch TL J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886 [TBL] [Abstract][Full Text] [Related]
8. Sustained NFAT signaling promotes a Th1-like pattern of gene expression in primary murine CD4+ T cells. Porter CM; Clipstone NA J Immunol; 2002 May; 168(10):4936-45. PubMed ID: 11994444 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. Bao M; Yang Y; Jun HS; Yoon JW J Immunol; 2002 May; 168(10):5369-75. PubMed ID: 11994496 [TBL] [Abstract][Full Text] [Related]
10. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704 [TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317 [TBL] [Abstract][Full Text] [Related]
12. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337 [TBL] [Abstract][Full Text] [Related]
13. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice. Oikawa Y; Shimada A; Kasuga A; Morimoto J; Osaki T; Tahara H; Miyazaki T; Tashiro F; Yamato E; Miyazaki J; Saruta T J Immunol; 2003 Dec; 171(11):5865-75. PubMed ID: 14634096 [TBL] [Abstract][Full Text] [Related]
14. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616 [TBL] [Abstract][Full Text] [Related]
15. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018 [TBL] [Abstract][Full Text] [Related]
16. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097 [TBL] [Abstract][Full Text] [Related]
17. Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background. Koarada S; Wu Y; Olshansky G; Ridgway WM J Immunol; 2002 Dec; 169(11):6580-7. PubMed ID: 12444170 [TBL] [Abstract][Full Text] [Related]
18. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Trembleau S; Penna G; Gregori S; Gately MK; Adorini L Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777 [TBL] [Abstract][Full Text] [Related]
19. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction. Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970 [TBL] [Abstract][Full Text] [Related]
20. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]